JWCAR201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JWCAR201, covering 2024-07-24 to 2024-07-24. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma [Phase 1]